Antiretroviral therapy in Indian setting: When & what to start with, when & what to switch to?

被引：23
|
作者：
Kumarasamy, N. [1 ,3 ]
Patel, Atul [2 ,3 ]
Pujari, Sanjay [3 ,4 ]
机构：
[1] YRG CARE Med Ctr, Voluntary Hlth Serv, Madras 600113, Tamil Nadu, India
[2] Vedant Inst Med Sci, Ahmadabad, Gujarat, India
[3] Inst Infect Dis, Pune, Maharashtra, India
[4] HIVMAI, Pune, Maharashtra, India
来源：
INDIAN JOURNAL OF MEDICAL RESEARCH | 2011年 / 134卷 / 06期
基金：
英国惠康基金;
关键词：
Antiretroviral drugs; antiretroviral therapy; ART; CD4; HIV; IRIS; viral load; RECONSTITUTION INFLAMMATORY SYNDROME; HIV-INFECTED PATIENTS; CD4 CELL COUNTS; COST-EFFECTIVENESS ANALYSIS; ZIDOVUDINE-INDUCED ANEMIA; LONG-TERM EFFICACY; LINE VIRAL LOAD; IMMUNE RECONSTITUTION; RISK-FACTORS; DRUG-RESISTANCE;
D O I：
10.4103/0971-5916.92626
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
With the rapid scale up of antiretroviral therapy, there is a dramatic decline in HIV related morbidity and mortality in both developed and developing countries. Several new safe antiretroviral, and newer class of drugs and monitoring assays are developed recently. As a result the treatment guideline for the management of HIV disease continue to change. This review focuses on evolving science on Indian policy - antiretroviral therapy initiation, which drugs to start with, when to change the initial regimen and what to change.
引用
收藏
页码：787 / 800
页数：14
相关论文
共 50 条
  • [41] Neoadjuvant Therapy: What, When and Why
    Smith, I.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S41 - S41
  • [42] Preoperative therapy: what, when and for whom?
    von Minckwitz, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 113 - 116
  • [43] What Happens When Subjects Are Not Ready for a Task Switch
    Dixon, Peter
    CANADIAN JOURNAL OF EXPERIMENTAL PSYCHOLOGY-REVUE CANADIENNE DE PSYCHOLOGIE EXPERIMENTALE, 2014, 68 (04): : 253 - 253
  • [44] Antiretroviral treatment: when and how start?
    Soriano, V
    Jimenez-Nacher, I
    MEDICINA CLINICA, 1998, 111 (04): : 137 - 141
  • [45] When to start renal replacement therapy in acute kidney injury: What are we waiting for?
    Liu, Lixia
    Hu, Zhenjie
    JOURNAL OF INTENSIVE MEDICINE, 2024, 4 (03): : 341 - 346
  • [46] Mucolytic Therapy: What, When, Where, Why, and What Is the Evidence?
    Kelly, H. William
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2010, 23 (02) : 151 - 154
  • [47] Setting conservation priorities when what you see is not what you get
    Vellend, Mark
    Kharouba, Heather M.
    ANIMAL CONSERVATION, 2013, 16 (01) : 14 - 15
  • [48] When to start antiretroviral therapy in HIV-2: the challenge remains
    Cardoso, M.
    Pimentel, B.
    Granado, J.
    Vasconcelos, J.
    Miranda, A.
    Peres, S.
    Baptista, T.
    Mansinho, K.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [49] When to start therapy
    Phillips, A
    Lampe, F
    JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (05): : 821 - 821
  • [50] Age-Old Questions: When to Start Antiretroviral Therapy and in Whom?
    Walensky, Rochelle P.
    Hirsch, Martin S.
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (07) : 1196 - 1198
12345